Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McEwen Inc. (MUX) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, together with AI-assisted summaries to help interpret complex documents. As a Colorado corporation listed on the New York Stock Exchange, McEwen files current reports on Form 8-K and other periodic reports that describe material events affecting its gold, silver and copper business across the Americas.
In recent Form 8-K filings, McEwen has reported on a range of topics, including the business combination with Canadian Gold Corp. that added the Tartan Mine Project in Manitoba, the extension of the Environmental Impact Assessment for the El Gallo Mine in Mexico, and strategic investments such as the share exchange agreement to acquire an interest in Paragon Geochemical Laboratories. Other 8-Ks discuss financing transactions like flow-through share offerings, appointments of senior executives, and technical and feasibility milestones at the Los Azules copper project in San Juan, Argentina.
Through this page, users can review McEwen’s filings to see how the company describes its operations at the Gold Bar Mine Complex in Nevada, the Fox Complex in Ontario, the San José Mine in Argentina, the El Gallo Mine in Mexico and its 46.4% interest in McEwen Copper. AI-powered tools highlight key sections of lengthy filings, such as risk factor discussions, descriptions of material agreements, and summaries of technical and permitting developments.
Investors researching MUX can use the filings page to locate quarterly and annual reports when available (Forms 10-Q and 10-K), current reports on Form 8-K, and exhibits referenced in those filings. The inclusion of insider and financing-related disclosures, where filed, helps users understand equity issuances, ownership changes and other regulatory events that may influence the company’s capital structure and project funding.
Stephen Douglas Kaszas, a director of McEwen Inc. (MUX), was granted a stock option on 08/11/2025 to buy 10,000 shares of common stock at an exercise price of $10.43. The Form 4 reports the option as an acquisition and shows 10,000 derivative securities beneficially owned following the transaction, held directly. The option vests in three equal annual installments beginning August 11, 2026 and the option expires on August 11, 2030. The filing was made by one reporting person and identifies Kaszas relationship to the issuer as a director.
McEwen Inc. insider Robert Ross McEwen, who serves as Chief Executive Officer, a director and a greater-than-10% owner, was granted a stock option that gives him the right to buy 170,000 shares of McEwen Inc. common stock at an exercise price of $10.43 per share. The transaction is dated 08/11/2025 and the option expires on 08/11/2030. The options are documented as a stock option (right to buy) and are held directly by Mr. McEwen.
The grant vests in three equal annual installments beginning on 08/11/2026, which staggers exercisability over three years. Following the reported transaction, Mr. McEwen beneficially owns 170,000 options. The filing discloses standard Section 16 insider compensation activity without additional context on total outstanding shares or aggregate insider holdings in the filing text provided.
Jeffrey Chan, McEwen Inc.'s VP-Finance, reported equity awards dated 08/11/2025: a stock option to purchase 40,000 shares at an exercise price of $10.43 (expiration 08/11/2030) and 3,800 restricted stock units (RSUs). The option vests in three equal annual installments beginning 08/11/2026. The RSUs vest in three approximately equal installments on 12/29/2025, 06/29/2026 and 12/29/2026.
Each RSU represents a contingent right to one share of common stock or the cash value thereof as provided in the award agreement. Both grants are reported as direct beneficial ownership. The filing records compensation-related awards rather than open-market purchases or dispositions.
McEwen Inc. (MUX) director Michelle Makori was granted 20,000 stock options with an exercise price of $10.43 on 08/11/2025. The options are exercisable for common stock, held directly, and the grant leaves the reporting person with 20,000 derivative securities following the transaction.
The options vest in three equal annual installments beginning on August 11, 2026 and carry an expiration date of 08/11/2030. This filing records a standard equity grant to a director: it details the grant size, strike price, vesting schedule and expiration but contains no additional cash sales, purchases or other compensation adjustments.
McEwen Inc. reporting person Ian J. Ball, a director, acquired derivative securities in the form of stock options. The Form 4 shows an acquisition of 20,000 stock options with an exercise price of $10.43. The transaction date recorded is 08/11/2025, and the options vest in three equal annual installments beginning on August 11, 2026. The options have an expiration date listed as 08/11/2030 and are reported as directly owned following the transaction. The filing does not disclose any cash payment amount for the grant beyond the stated exercise price or any change in other holdings.
McEwen Inc. issued a press release on August 7, 2025 summarizing its second quarter and half‑year financial and operating results and providing certain operational updates; that press release is furnished as Exhibit 99.1 to this Form 8-K.
The filing states the information furnished under Item 2.02 is not to be deemed "filed" for purposes of Section 18 and is not incorporated by reference in other Securities Act filings. The document includes a cautionary statement that the press release contains forward‑looking statements about production, costs, exploration, development and financing and refers readers to the company’s 2024 Form 10-K and other filings for risk factors. The report is signed by Carmen Diges, General Counsel, dated August 8, 2025.